Abstract
GLIAL-CELL-LINE-DERIVED neurotrophic factor (GDNF) promotes survival of embryonic dopaminergic neurons in culture1, and its expression pattern suggests a role as a transient target-derived trophic factor for dopaminergic neurons of the substantia nigra2–4. These neurons participate in the control of motor activity, emotional status and cognition5, and they degenerate in Parkinson's disease for unknown reasons. To test whether GDNF has a trophic effect on dopaminergic neurons in the adult brain, we used a rat model in which these neurons are induced to degenerate by transecting their axons within the medial forebrain bundle6. We report here that axotomy resulted in loss of half the tyrosine hydroxylase-expressing neurons in the substantia nigra. This loss was largely prevented by repeated injections of GDNF adjacent to the substantia nigra. Our findings suggest that GDNF or related molecules may be useful for the treatment of Parkinson's disease.
Similar content being viewed by others
References
Lin, L. F. H., Doherty, D. H., Lile, D., Beketsh, S. & Collins, F. Science 260, 1130–1132 (1993).
Schaar, D. B., Sieber, B. A., Dreyfus, C. F. & Black, I. B. Expl Neurol. 124, 368–371 (1993).
Strömberg, I. et al. Expl Neurol. 124, 401–412 (1993).
Poulsen, K. et al. Neuron 13, 1245–1252 (1994).
Björklund, A. & Lindvall, O. in Handbook of Chemical Neuroanatomy (eds Björklund, A. & Hökfelt, T.) 55–122 (Elsevier, Amsterdam, 1984).
Knüsel, B. et al. J. Neurosci. 12, 4391–4402 (1992).
Hynes, M. A. et al. J. Neurosci. Res. 37, 144–154 (1994).
Hagg, T. & Varon, S. Proc. natn. Acad. Sci. U.S.A. 90, 6315–6319 (1993).
Knüsel, B. et al. J. Neurosci. 10, 558–570 (1990).
Otto, D. & Unsicker, K. J. Neurosci. 10, 1912–1921 (1990).
Alexi, T. & Hefti, F. Neuroscience 55, 903–910 (1993).
Araujo, D. M., Lapchak, P. A. & Hefti, F. J. Neurochem. 61, 899–910 (1993).
Hagg, T. Soc. Neurosci. Abs. 20, 193.5 (1994).
Hefti, F. J. Neurosci. 6, 2155–2162 (1986).
Sendtner, M., Kreutzberg, G. W. & Thoenen, H. Nature 345, 440–441 (1990).
Grothe, C. & Unsicker, K. J. Neurosci. Res. 32, 317–328 (1992).
Sendtner, M., Holtmann, B., Kolbeck, R., Thoenen, H. & Barde, Y.-A. Nature 360, 757–759 (1992).
Yan, Q., Elliott, J. & Snider, W. D. Nature 360, 753–755 (1992).
Hughes, R. A., Sendtner, M. & Thoenen, H. J. Neurosci. Res. 36, 663–671 (1993).
Koliatsos, V. E., Clatterbuck, R. E., Winslow, J. W., Cayouette, M. H. & Price, D. L. Neuron 10, 359–367 (1993).
Yan, Q. et al. J. Neurobiol. 24, 1555–1577 (1993).
Clatterbuck, R. E., Price, D. L. & Koliatsos, V. E. Proc. natn. Acad. Sci. U.S.A. 90, 2222–2226 (1993).
Cummings, B. J., Yee, G. J. & Cotman, C. W. Brain Res. 591, 271–276 (1992).
Schmidt-Kastner, R. et al. Molec. Brain Res. 26, 325–330 (1994).
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Beck, K., Valverde, J., Alexi, T. et al. Mesencephalic dopaminergic neurons protected by GDNF from axotomy-induced degeneration in the adult brain. Nature 373, 339–341 (1995). https://doi.org/10.1038/373339a0
Received:
Accepted:
Issue Date:
DOI: https://doi.org/10.1038/373339a0
- Springer Nature Limited
This article is cited by
-
Unraveling the role of glial cell line–derived neurotrophic factor in the treatment of Parkinson’s disease
Neurological Sciences (2024)
-
Glial cell line-derived neurotrophic factors (GFLs) and small molecules targeting RET receptor for the treatment of pain and Parkinson’s disease
Cell and Tissue Research (2020)
-
Promoting neuroregeneration after perinatal arterial ischemic stroke: neurotrophic factors and mesenchymal stem cells
Pediatric Research (2018)
-
Neurotoxins as Preclinical Models for Parkinson’s Disease
Neurotoxicity Research (2018)
-
MicroRNAs in Parkinson’s disease
Experimental Brain Research (2017)